Some T. gondii candidate antigens to be used in vaccination were identified [33]. They include the major tachyzoite surface antigens: SAG1 (30 kDa), SAG2 (22 kDa) and SAG3 (43 kDa), which are conserved among different strains of T. gondii and seem to be involved in the process of cell invasion [34], [35], [36], [37] and [38]. In the present work, we have generated a recombinant Influenza A vector harboring a dicistronic

NA segment encoding SAG2 of T. gondii (NA38-SAG2) and we explored an original heterologous prime-boost immunization protocol using influenza virus (FLU-SAG2) and a recombinant adenovirus (Ad-SAG2). Recombinant FLU-SAG2 was able to replicate in cell culture and in lungs of infected mice. In addition, in mice primed with Olaparib mouse FLU-SAG2 and boosted with Ad-SAG2, we detected specific humoral and cellular anti-SAG2 immune responses. Finally, when the immunized mice were orally challenged with the cystogenic P-Br strain of T. gondii, they displayed a significant reduction of parasite burden in brain. Taken together, our results show that recombinant influenza viruses this website may be a useful tool aiming the development of vaccines against protozoan parasites.

Female BALB/c and Swiss-Webster mice, 10–12 weeks old were obtained from the animal facilities of the Federal University of Minas Gerais (Centro de Bioterismo [CEBIO], Belo Horizonte, Brazil) and housed according to institutional standard guidelines. MDCK cells were grown at 37 °C and 5% CO2 in complete Dulbecco’s modified Eagle Medium (DMEM; SIGMA) with 1 mM sodium pyruvate, 4.5 mg/ml l-glucose, 100 U/ml

penicillin and 100 μg/ml streptomycin, herein named complete DMEM, and supplemented with 5% heat inactivated fetal calf serum (FCS; CUTILAB). HEK293T cells were grown in complete DMEM supplemented with 10% FCS. The P-Br and RH strains of T. gondii were maintained by successive inoculations in Swiss-Webster mice as previously described [39]. RH tachyzoites were used to purify an extract of GPI-anchored membrane proteins (F3 fraction), according MycoClean Mycoplasma Removal Kit to the protocol previously described [40]. Influenza segments transfer plasmids pPOL-HA, M, NS, PB2, PB1, PA and NP and the expression plasmids pcDNA-PA, NP, PB1 and PB2 were kindly provided by Dr George Brownlee (Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom) [41]. Plasmids pPRNA and pPRNA38 were constructed as previously described [27] and [28] and encode, respectively, the wild type and recombinant NA segments of the A/WSN/33 (H1N1) influenza virus. Vector pPRNA38 was prepared by digestion with XhoI and treatment with Klenow enzyme (PROMEGA) followed by dephosphorylation with Shrimp Alkaline Phosphatase (SAP; PROMEGA). The SAG2 coding sequence was obtained from plasmid pAd-SAG2 [39] by digestion with BglII and HindIII (PROMEGA).